BioScrip® is a leading provider in comprehensive, cost-effective pharmaceutical and home care solutions. Our goal is to partner with patients, physicians, healthcare payors, government agencies and pharmaceutical manufacturers to provide access to infusible medications and management solutions that optimize outcomes for chronic and other complex healthcare conditions. At BioScrip, our patients receive personalized, safe, effective and convenient infusion therapies to help improve quality of life. Our team of professionals assist each patient in every step of their office or home infusion experience.
Company Growth (employees)
Denver, US
Size (employees)
2,039 (est)+11%
BioScrip is headquartered in Denver, US

Key People at BioScrip

Richard M. Smith

Richard M. Smith

President & CEO
Hai Tran

Hai Tran


BioScrip Office Locations

BioScrip has offices in Denver, Eden Prairie, Elmsford
Denver, US
Elmsford, US
Eden Prairie, US

BioScrip Metrics

BioScrip Summary

Market capitalization

$229.9 m

Closing share price

BioScrip's current market capitalization is $229.9 m.

BioScrip Financials

BioScrip's revenue is $935.6 m in FY, 2016 which is a 4.7% decrease from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016


$842.2 m$984.1 m$982.2 m$935.6 m

Revenue growth, %


Cost of goods sold

$721.3 m$670 m

Gross profit

$271.8 m$261.1 m$260.9 m

Operating expense total

$166 m


($7 m)($91.1 m)($287.6 m)

Interest expense

$37.3 m$38.2 m

Interest income

$37.3 m

Income tax expense

($21.5 m)$2 m

Net Income

($69.7 m)($147.5 m)($299.7 m)($41.5 m)

Operating cash flow

($61.1 m)($261 k)$14.8 m

BioScrip Market Value History

BioScrip Online Presence

BioScrip News

BioScrip Company Life

You may also be interested in